Finepoint Capital »

Eyepoint Pharmaceuticals shares owned by Finepoint Capital

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 657k 20.67

More positions owned by Finepoint Capital

Liberty Broadband Corp Com Ser C (LBRDK)
Springworks Therapeutics (SWTX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arvinas Ord (ARVN)
Revolution Medicines (RVMD)
Sarepta Therapeutics (SRPT)
Argenx Se Sponsored Adr (ARGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cytokinetics Com New (CYTK)
Galapagos Nv Spon Adr (GLPG)
ACADIA Pharmaceuticals (ACAD)
Eyepoint Pharmaceuticals Com New (EYPT)
Dish Network Corporation Note 12/1 (Principal)
Solid Biosciences Com New (SLDB)
Travere Therapeutics (TVTX)

View all positions for Finepoint Capital

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Adage Capital Partners GP
Suvretta Capital Management
Franklin Resources
BlackRock
T. Rowe Price Associates
Vanguard Group
Millennium Management
T. Rowe Price Investment Management
Citadel Advisors
Morgan Stanley
Octagon Capital Advisors
RA Capital Management
Ikarian Capital
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals